Skip to content
LinkedInEmail
+46 (0)8 621 05 02|info@key2compliance.com
Gate2Compliance ™ Logo Gate2Compliance ™ Logo
Your free source for Life Science Regulatory Compliance documents.
  • HOME
  • CONTENT
    • Restricted content
    • Restricted content
    • Restricted content
    • Restricted content
      • Restricted content
      • Restricted content
    • GLOSSARY
    • Acronyms and Abbreviations
  • ABOUT
  • ACCOUNT
  • FAQ
  • LOG IN
  • REGISTER

FDA GFI, Patient-Focused Drug Development: Fit-for Purpose Clinical Outcome Assessments, DRAFT, 06/22

Previous Next
FDA GFI, Patient-Focused Drug Development: Fit-for Purpose Clinical Outcome Assessments, DRAFT, 06/22
Beatrice Burtsov2022-09-07T05:11:46+00:00September 7th, 2022|

About the Author: Beatrice Burtsov

Beatrice Burtsov
Risk Management according to 14971:2019
  • +46 (0)8 621 05 02
  • info@key2compliance.com
  •  Follow Us
  • About
  • Privacy
  • FAQ
  • News

© Copyright Key2Compliance AB 2023

Go to Top